Antibiotics for secondary prevention of coronary heart disease

  • Protocol
  • Intervention

Authors

  • Maria Skoog,

    Corresponding author
    1. Rigshospitalet, Copenhagen University Hospital, Copenhagen Trial Unit, Centre for Clinical Intervention Research, Department 7812, Copenhagen, Denmark
    • Maria Skoog, Copenhagen Trial Unit, Centre for Clinical Intervention Research, Department 7812, Rigshospitalet, Copenhagen University Hospital, Blegdamsvej 9, Copenhagen, DK-2100, Denmark. MS@ctu.dk.

    Search for more papers by this author
  • Berit Grevstad,

    1. Rigshospitalet, Copenhagen University Hospital, Copenhagen Trial Unit, Centre for Clinical Intervention Research, Department 7812, Copenhagen, Denmark
    Search for more papers by this author
  • Jørn Wetterslev,

    1. Rigshospitalet, Copenhagen University Hospital, Copenhagen Trial Unit, Centre for Clinical Intervention Research, Department 7812, Copenhagen, Denmark
    Search for more papers by this author
  • Asbjørn Hróbjartsson,

    1. Rigshospitalet, The Nordic Cochrane Centre, Copenhagen, Denmark
    Search for more papers by this author
  • Christian Gluud

    1. Copenhagen Trial Unit, Centre for Clinical Intervention Research, Department 7812, Rigshospitalet, Copenhagen University Hospital, The Cochrane Hepato-Biliary Group, Copenhagen, Denmark
    Search for more papers by this author

Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:

To assess the beneficial and harmful effects of antibiotics given as secondary prevention to patients with CHD.